Why we need a national strategy for liver disease
Why we need a national strategy for liver disease
For the last 10 years the British Association for the Study of the Liver and the British Society of Gastroenterology Liver Section have been campaigning for greater recognition of liver disease as an important priority for the NHS. Deaths from liver disease are escalating at a frightening rate (Figure 1) (British Association for the Study of the Liver, 2009). Based on current trends, the death rate from liver disease will exceed cardiac deaths by 2030. This needs to be reversed before we get to this ridiculous scenario - over 95% of all liver diseases are entirely preventable or treatable, and deaths from liver disease occur at an average age of 55 years rather than ~82 years for cardiac disease or stroke. To stop this we need to reduce the rising tide of alcoholic liver disease and fatty liver disease, and actively treat the increasing number of patients with chronic hepatitis B and C
674-675
Moore, Kevin
0f0c315d-93bd-4231-8ad1-aa11ac9dbf10
Sheron, Nick
cbf852e3-cfaa-43b2-ab99-a954d96069f1
December 2009
Moore, Kevin
0f0c315d-93bd-4231-8ad1-aa11ac9dbf10
Sheron, Nick
cbf852e3-cfaa-43b2-ab99-a954d96069f1
Moore, Kevin and Sheron, Nick
(2009)
Why we need a national strategy for liver disease.
British Journal of Hospital Medicine, 70 (12), .
Abstract
For the last 10 years the British Association for the Study of the Liver and the British Society of Gastroenterology Liver Section have been campaigning for greater recognition of liver disease as an important priority for the NHS. Deaths from liver disease are escalating at a frightening rate (Figure 1) (British Association for the Study of the Liver, 2009). Based on current trends, the death rate from liver disease will exceed cardiac deaths by 2030. This needs to be reversed before we get to this ridiculous scenario - over 95% of all liver diseases are entirely preventable or treatable, and deaths from liver disease occur at an average age of 55 years rather than ~82 years for cardiac disease or stroke. To stop this we need to reduce the rising tide of alcoholic liver disease and fatty liver disease, and actively treat the increasing number of patients with chronic hepatitis B and C
Text
BJHM_ed_LiverDiseaseAQcut.pdf
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Published date: December 2009
Additional Information:
Editorial
Identifiers
Local EPrints ID: 72577
URI: http://eprints.soton.ac.uk/id/eprint/72577
ISSN: 1750-8460
PURE UUID: 3fedae5f-94e1-4443-ad21-e6a0a40c1018
Catalogue record
Date deposited: 19 Feb 2010
Last modified: 13 Mar 2024 21:33
Export record
Contributors
Author:
Kevin Moore
Author:
Nick Sheron
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics